Targeting the major pro-inflammatory interleukin-6-type cytokine receptor gp130 by antagonistic single domain antibodies
IntroductionAlthough Interleukin (IL)-6-type cytokine signaling is critical for maintaining the body’s homeostasis, aberrant signaling has been observed in numerous diseases including autoimmunity and cancer. Currently, all approved biologics that inhi…